ID   PTN7_RAT                Reviewed;         359 AA.
AC   P49445;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1996, sequence version 1.
DT   24-JUL-2024, entry version 155.
DE   RecName: Full=Tyrosine-protein phosphatase non-receptor type 7;
DE            EC=3.1.3.48;
DE   AltName: Full=Hematopoietic protein-tyrosine phosphatase;
DE            Short=HEPTP;
DE   AltName: Full=Protein-tyrosine phosphatase LC-PTP;
GN   Name=Ptpn7; Synonyms=Lcptp;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7545170; DOI=10.1074/jbc.270.37.21902;
RA   Swieter M., Berenstein E.H., Swaim W.D., Siraganian R.P.;
RT   "Aggregation of IgE receptors in rat basophilic leukemia 2H3 cells induces
RT   tyrosine phosphorylation of the cytosolic protein-tyrosine phosphatase
RT   HePTP.";
RL   J. Biol. Chem. 270:21902-21906(1995).
RN   [2]
RP   SUBCELLULAR LOCATION, OXIDATION AT CYS-290, AND ACTIVITY REGULATION.
RX   PubMed=20157115; DOI=10.1074/jbc.m109.052555;
RA   Heneberg P., Draberova L., Bambouskova M., Pompach P., Draber P.;
RT   "Down-regulation of protein-tyrosine phosphatases activates an immune
RT   receptor in the absence of its translocation into lipid rafts.";
RL   J. Biol. Chem. 285:12787-12802(2010).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-93, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: May play a role in the regulation of T and B-lymphocyte
CC       development and signal transduction. {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-tyrosyl-[protein] = L-tyrosyl-[protein] +
CC         phosphate; Xref=Rhea:RHEA:10684, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620; EC=3.1.3.48; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU10044};
CC   -!- ACTIVITY REGULATION: Inhibited in cells after FCER1A triggering.
CC       {ECO:0000269|PubMed:20157115}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:20157115}.
CC   -!- PTM: Oxidized at active site cysteine. Treatment with pervanadate
CC       (vanadate and H(2)O(2)) or with antigen enhanced oxidation of active
CC       site cysteine. {ECO:0000269|PubMed:20157115}.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family. Non-
CC       receptor class subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U28356; AAA84443.1; -; mRNA.
DR   RefSeq; NP_663716.1; NM_145683.1.
DR   RefSeq; XP_006249883.1; XM_006249821.3.
DR   AlphaFoldDB; P49445; -.
DR   SMR; P49445; -.
DR   STRING; 10116.ENSRNOP00000007833; -.
DR   iPTMnet; P49445; -.
DR   PhosphoSitePlus; P49445; -.
DR   PaxDb; 10116-ENSRNOP00000007833; -.
DR   Ensembl; ENSRNOT00000007833.4; ENSRNOP00000007833.1; ENSRNOG00000005807.4.
DR   Ensembl; ENSRNOT00055037320; ENSRNOP00055030405; ENSRNOG00055021781.
DR   Ensembl; ENSRNOT00060025886; ENSRNOP00060020704; ENSRNOG00060015102.
DR   Ensembl; ENSRNOT00065032584; ENSRNOP00065026009; ENSRNOG00065019361.
DR   GeneID; 246781; -.
DR   KEGG; rno:246781; -.
DR   UCSC; RGD:708516; rat.
DR   AGR; RGD:708516; -.
DR   CTD; 5778; -.
DR   RGD; 708516; Ptpn7.
DR   eggNOG; KOG0789; Eukaryota.
DR   GeneTree; ENSGT00940000160979; -.
DR   HOGENOM; CLU_001645_10_3_1; -.
DR   InParanoid; P49445; -.
DR   OMA; GYDGREK; -.
DR   OrthoDB; 2914248at2759; -.
DR   PhylomeDB; P49445; -.
DR   TreeFam; TF331016; -.
DR   Reactome; R-RNO-5675221; Negative regulation of MAPK pathway.
DR   PRO; PR:P49445; -.
DR   Proteomes; UP000002494; Chromosome 13.
DR   Bgee; ENSRNOG00000005807; Expressed in thymus and 19 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0009898; C:cytoplasmic side of plasma membrane; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0072686; C:mitotic spindle; IEA:Ensembl.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IBA:GO_Central.
DR   CDD; cd14612; PTPc-N7; 1.
DR   Gene3D; 3.90.190.10; Protein tyrosine phosphatase superfamily; 1.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTP_cat.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; Tyr_Pase_dom.
DR   InterPro; IPR008356; Tyr_Pase_KIM-con.
DR   PANTHER; PTHR46198; PROTEIN-TYROSINE-PHOSPHATASE; 1.
DR   PANTHER; PTHR46198:SF3; PROTEIN-TYROSINE-PHOSPHATASE; 1.
DR   Pfam; PF00102; Y_phosphatase; 1.
DR   PRINTS; PR01778; KIMPTPASE.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   SMART; SM00194; PTPc; 1.
DR   SMART; SM00404; PTPc_motif; 1.
DR   SUPFAM; SSF52799; (Phosphotyrosine protein) phosphatases II; 1.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 1.
PE   1: Evidence at protein level;
KW   Cytoplasm; Cytoskeleton; Hydrolase; Oxidation; Phosphoprotein;
KW   Protein phosphatase; Reference proteome.
FT   CHAIN           1..359
FT                   /note="Tyrosine-protein phosphatase non-receptor type 7"
FT                   /id="PRO_0000094763"
FT   DOMAIN          97..349
FT                   /note="Tyrosine-protein phosphatase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00160"
FT   REGION          1..34
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          38..51
FT                   /note="Interaction with MAP kinases"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        290
FT                   /note="Phosphocysteine intermediate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00160,
FT                   ECO:0000255|PROSITE-ProRule:PRU10044"
FT   BINDING         257
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         290..296
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         334
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         44
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P35236"
FT   MOD_RES         66
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P35236"
FT   MOD_RES         93
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         143
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P35236"
FT   MOD_RES         290
FT                   /note="Cysteine sulfenic acid (-SOH)"
FT                   /evidence="ECO:0000269|PubMed:20157115"
SQ   SEQUENCE   359 AA;  40314 MW;  5B98E196DB633677 CRC64;
     MVQACEGRSR AQLPTLSLGA DMTQPPPAKA PAKKHVRLQE RRGSSVALML DVRSLGTVEP
     ICSVNTPREV TLHFLRTAGH PLTRWTLQHQ PPSPKQLEEE FLKIPSNFVN PEDLDIPGHA
     SKDRYKTILP NPQSRVCLGR AHSQEDSDYI NANYIRGYDG KEKVYIATQG PMPNTVADFW
     EMVWQEDVSL IVMLTQLREG KEKCVHYWPT EEEAYGPFQI RIQGMKEHPE YTVRHLTIQH
     QQECRSVKHI LFSAWPDHQT PESAGPLLRL VAEVETPETA ANSGPIVVHC SAGIGRTGCF
     IATRIGCQQL KARGEVDILG IVCQLRLDRG GMIQTAEQYQ FLHHTLALYA AQLPPETDP
//
